Single Genome Sequencing of Expressed and Proviral HIV-1 Envelope Glycoprotein 120 (gp120) and nef Genes.

The current study provides detailed protocols utilized to amplify the complete HIV-1 gp120 and nef genes from single copies of expressed or integrated HIV present in fresh-frozen autopsy tissues of patients who died while on combined antiretroviral therapy (cART) with no detectable plasma viral load (pVL) at death ( Lamers et al., 2016a and 2016b; Rose et al., 2016 ). This method optimizes protocols from previous publications ( Palmer et al., 2005 ; Norström et al., 2012 ; Lamers et al., 2015 ; 2016a and 2016b; Rife et al., 2016 ) to produce single distinct PCR products that can be directly sequenced and includes several cost-saving and time-efficient modifications.

[1]  Abraham J. Kandathil,et al.  Are T cells the only HIV-1 reservoir? , 2016, Retrovirology.

[2]  G. Fogel,et al.  HIV-1 Evolutionary Patterns Associated with Metastatic Kaposi's Sarcoma during AIDS , 2016, Sarcoma.

[3]  S. Hughes,et al.  Multiple Origins of Virus Persistence during Natural Control of HIV Infection , 2016, Cell.

[4]  Shuntai Zhou,et al.  Diversity and Tropism of HIV-1 Rebound Virus Populations in Plasma Level After Treatment Discontinuation. , 2016, The Journal of infectious diseases.

[5]  G. Fogel,et al.  HIV DNA Is Frequently Present within Pathologic Tissues Evaluated at Autopsy from Combined Antiretroviral Therapy-Treated Patients with Undetectable Viral Loads , 2016, Journal of Virology.

[6]  O. Pybus,et al.  HIV Maintains an Evolving and Dispersed Population in Multiple Tissues during Suppressive Combined Antiretroviral Therapy in Individuals with Cancer , 2016, Journal of Virology.

[7]  L. Ndhlovu,et al.  Strategies to target non-T-cell HIV reservoirs , 2016, Current opinion in HIV and AIDS.

[8]  M. Salemi,et al.  Evolution of Neuroadaptation in the Periphery and Purifying Selection in the Brain Contribute to Compartmentalization of Simian Immunodeficiency Virus (SIV) in the Brains of Rhesus Macaques with SIV-Associated Encephalitis , 2016, Journal of Virology.

[9]  M. Salemi,et al.  Phylogenetics and Phyloanatomy of HIV/SIV Intra-Host Compartments and Reservoirs: The Key Role of the Central Nervous System. , 2016, Current HIV research.

[10]  S. Hughes,et al.  Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo , 2016, Proceedings of the National Academy of Sciences.

[11]  M. Lederman,et al.  Origin of Rebound Plasma HIV Includes Cells with Identical Proviruses That Are Transcriptionally Active before Stopping of Antiretroviral Therapy , 2015, Journal of Virology.

[12]  T. Leitner,et al.  Recombination elevates the effective evolutionary rate and facilitates the establishment of HIV-1 infection in infants after mother-to-child transmission , 2015, Retrovirology.

[13]  Nancie M Archin,et al.  Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies. , 2015, The Journal of infectious diseases.

[14]  Roger E Bumgarner,et al.  Comparison of Major and Minor Viral SNPs Identified through Single Template Sequencing and Pyrosequencing in Acute HIV-1 Infection , 2015, PloS one.

[15]  G. Fogel,et al.  Tracking the Emergence of Host-Specific Simian Immunodeficiency Virus env and nef Populations Reveals nef Early Adaptation and Convergent Evolution in Brain of Naturally Progressing Rhesus Macaques , 2015, Journal of Virology.

[16]  Amit Kumar,et al.  Eradication of HIV-1 from the Macrophage Reservoir: An Uncertain Goal? , 2015, Viruses.

[17]  L. White,et al.  Single genome amplification and standard bulk PCR yield HIV-1 envelope products with similar genotypic and phenotypic characteristics. , 2015, Journal of virological methods.

[18]  A. Haase,et al.  Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption , 2015, Proceedings of the National Academy of Sciences.

[19]  M. Markowitz,et al.  Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope , 2014, Retrovirology.

[20]  F. Ceccherini‐Silberstein,et al.  Understanding HIV Compartments and Reservoirs , 2014, Current HIV/AIDS Reports.

[21]  J. Mellors,et al.  Lack of Detectable HIV-1 Molecular Evolution during Suppressive Antiretroviral Therapy , 2014, PLoS pathogens.

[22]  E. Rosenberg,et al.  HIV-1 persistence in CD4+ T cells with stem cell-like properties , 2014, Nature Medicine.

[23]  P. Lemey,et al.  The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time , 2013, Proceedings of the National Academy of Sciences.

[24]  Sarah B. Laskey,et al.  Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure , 2013, Cell.

[25]  Sikhulile Moyo,et al.  Intra-host evolutionary rates in HIV-1C env and gag during primary infection. , 2013, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[26]  R. Siliciano,et al.  Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies , 2013, PLoS pathogens.

[27]  Cassandra B. Jabara,et al.  Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children , 2012, PLoS pathogens.

[28]  J. Mullins,et al.  An Increasing Proportion of Monotypic HIV-1 DNA Sequences during Antiretroviral Treatment Suggests Proliferation of HIV-Infected Cells , 2012, Journal of Virology.

[29]  Melissa M. Norström,et al.  Combination of Immune and Viral Factors Distinguishes Low-Risk versus High-Risk HIV-1 Disease Progression in HLA-B*5701 Subjects , 2012, Journal of Virology.

[30]  M. Nei,et al.  MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. , 2011, Molecular biology and evolution.

[31]  P. Sharp,et al.  Intercompartmental Recombination of HIV-1 Contributes to env Intrahost Diversity and Modulates Viral Tropism and Sensitivity to Entry Inhibitors , 2011, Journal of Virology.

[32]  John M. Coffin,et al.  Clonal Sequences Recovered from Plasma from Patients with Residual HIV-1 Viremia and on Intensified Antiretroviral Therapy Are Identical to Replicating Viral RNAs Recovered from Circulating Resting CD4+ T Cells , 2011, Journal of Virology.

[33]  J. Coffin,et al.  Comparison of standard PCR/cloning to single genome sequencing for analysis of HIV-1 populations. , 2010, Journal of virological methods.

[34]  John W. Mellors,et al.  Multiple, Linked Human Immunodeficiency Virus Type 1 Drug Resistance Mutations in Treatment-Experienced Patients Are Missed by Standard Genotype Analysis , 2005, Journal of Clinical Microbiology.

[35]  R. Shafer,et al.  Reproducibility of human immunodeficiency virus type 1 (HIV-1) protease and reverse transcriptase sequencing of plasma samples from heavily treated HIV-1-infected individuals. , 2000, Journal of virological methods.

[36]  T. Merigan,et al.  Highly drug-resistant HIV-1 clinical isolates are cross-resistant to many antiretroviral compounds in current clinical development. , 1999, AIDS.

[37]  J. Thompson,et al.  The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. , 1997, Nucleic acids research.

[38]  R Brookmeyer,et al.  Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. , 1997, Science.

[39]  J Leibowitch,et al.  Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. , 1997, Science.

[40]  A. Rodrigo,et al.  Quantitation of target molecules from polymerase chain reaction-based limiting dilution assays. , 1997, AIDS research and human retroviruses.

[41]  R. Siliciano,et al.  Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection , 1997, Nature.

[42]  Robert F. Siliciano,et al.  In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency , 1995, Nature Medicine.